Search research articles
Contact Us
Filters
Showing results (171-180 of 184) with videos related to
Page
of 19
Sort By:
European Journal of Heart Failure
|
November 10, 2025
Adherence to guideline-directed medical treatments in heart failure. A scientific statement of the Heart Failure Association (HFA) of the ESC and the ESC Working Group on Cardiovascular Pharmacotherapy
Gianluigi Savarese, Felix Lindberg, Antonio Cannata, et al.
Nature Biotechnology
|
December 28, 2020
Hypertension delays viral clearance and exacerbates airway hyperinflammation in patients with COVID-19
Saskia Trump, Soeren Lukassen, Markus S Anker, et al.
European Journal of Heart Failure
|
October 2, 2020
Role of serum biomarkers in cancer patients receiving cardiotoxic cancer therapies: a position statement from the Cardio-Oncology Study Group of the Heart Failure Association and the Cardio-Oncology Council of the European Society of Cardiology
Radek Pudil, Christian Mueller, Jelena Čelutkienė, et al.
Faraday Discussions
|
December 18, 2024
Discovering synthesis targets: general discussion
Andy S Anker, Alán Aspuru-Guzik, Tim Bechtel, et al.
European Journal of Heart Failure
|
July 18, 2023
Patient phenotype profiling in heart failure with preserved ejection fraction to guide therapeutic decision making. A scientific statement of the Heart Failure Association, the European Heart Rhythm Association of the European Society of Cardiology, and the European Society of Hypertension
Stefan D Anker, Muhammad Shariq Usman, Markus S Anker, et al.
European Journal of Heart Failure
|
April 19, 2024
A roadmap for therapeutic discovery in pulmonary hypertension associated with left heart failure. A scientific statement of the Heart Failure Association (HFA) of the ESC and the ESC Working Group on Pulmonary Circulation & Right Ventricular Function
Pietro Ameri, Valentina Mercurio, Piero Pollesello, et al.
European Journal of Heart Failure
|
April 29, 2025
Ferric carboxymaltose assessment of morbidity and mortality in patients with iron deficiency and chronic heart failure (FAIR-HF2-DZHK05) trial: Baseline characteristics and comparison to other relevant clinical trials
Stefan D Anker, Tim Friede, Javed Butler, et al.
Chemical Science
|
December 12, 2024
Assessment of fine-tuned large language models for real-world chemistry and material science applications
Joren Van Herck, María Victoria Gil, Kevin Maik Jablonka, et al.
JAMA
|
March 30, 2025
Intravenous Ferric Carboxymaltose in Heart Failure With Iron Deficiency: The FAIR-HF2 DZHK05 Randomized Clinical Trial
Stefan D Anker, Tim Friede, Javed Butler, et al.
European Journal of Heart Failure
|
July 5, 2020
Role of cardiovascular imaging in cancer patients receiving cardiotoxic therapies: a position statement on behalf of the Heart Failure Association (HFA), the European Association of Cardiovascular Imaging (EACVI) and the Cardio-Oncology Council of the European Society of Cardiology (ESC)
Jelena Čelutkienė, Radek Pudil, Teresa López-Fernández, et al.
Page
of 19
Search research articles
Search
Showing results (171-180 of 184) with videos related to
Sort By:
Page
of 19
European Journal of Heart Failure
|
November 10, 2025
Adherence to guideline-directed medical treatments in heart failure. A scientific statement of the Heart Failure Association (HFA) of the ESC and the ESC Working Group on Cardiovascular Pharmacotherapy
Gianluigi Savarese, Felix Lindberg, Antonio Cannata, et al.
Nature Biotechnology
|
December 28, 2020
Hypertension delays viral clearance and exacerbates airway hyperinflammation in patients with COVID-19
Saskia Trump, Soeren Lukassen, Markus S Anker, et al.
European Journal of Heart Failure
|
October 2, 2020
Role of serum biomarkers in cancer patients receiving cardiotoxic cancer therapies: a position statement from the Cardio-Oncology Study Group of the Heart Failure Association and the Cardio-Oncology Council of the European Society of Cardiology
Radek Pudil, Christian Mueller, Jelena Čelutkienė, et al.
Faraday Discussions
|
December 18, 2024
Discovering synthesis targets: general discussion
Andy S Anker, Alán Aspuru-Guzik, Tim Bechtel, et al.
European Journal of Heart Failure
|
July 18, 2023
Patient phenotype profiling in heart failure with preserved ejection fraction to guide therapeutic decision making. A scientific statement of the Heart Failure Association, the European Heart Rhythm Association of the European Society of Cardiology, and the European Society of Hypertension
Stefan D Anker, Muhammad Shariq Usman, Markus S Anker, et al.
European Journal of Heart Failure
|
April 19, 2024
A roadmap for therapeutic discovery in pulmonary hypertension associated with left heart failure. A scientific statement of the Heart Failure Association (HFA) of the ESC and the ESC Working Group on Pulmonary Circulation & Right Ventricular Function
Pietro Ameri, Valentina Mercurio, Piero Pollesello, et al.
European Journal of Heart Failure
|
April 29, 2025
Ferric carboxymaltose assessment of morbidity and mortality in patients with iron deficiency and chronic heart failure (FAIR-HF2-DZHK05) trial: Baseline characteristics and comparison to other relevant clinical trials
Stefan D Anker, Tim Friede, Javed Butler, et al.
Chemical Science
|
December 12, 2024
Assessment of fine-tuned large language models for real-world chemistry and material science applications
Joren Van Herck, María Victoria Gil, Kevin Maik Jablonka, et al.
JAMA
|
March 30, 2025
Intravenous Ferric Carboxymaltose in Heart Failure With Iron Deficiency: The FAIR-HF2 DZHK05 Randomized Clinical Trial
Stefan D Anker, Tim Friede, Javed Butler, et al.
European Journal of Heart Failure
|
July 5, 2020
Role of cardiovascular imaging in cancer patients receiving cardiotoxic therapies: a position statement on behalf of the Heart Failure Association (HFA), the European Association of Cardiovascular Imaging (EACVI) and the Cardio-Oncology Council of the European Society of Cardiology (ESC)
Jelena Čelutkienė, Radek Pudil, Teresa López-Fernández, et al.
Page
of 19